Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$5.21
-0.38%
Mkt Cap $14.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | — | — | — | -$1.24 | $1.69 | +236.29% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.06 | -$0.13 | -116.67% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.21 | -$0.22 | -4.76% | — | — |
| Q1 2025 Mar 13, 2025 | — | — | — | -$0.23 | -$0.22 | +4.35% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.27 | -$0.25 | +7.41% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.32 | -$0.36 | -12.50% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | — | -$0.34 | — | — | — |
| Q1 2024 Mar 14, 2024 | — | — | — | -$0.18 | -$0.12 | +33.33% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.09 | -$0.17 | -88.89% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.40 | -$1.43 | -257.50% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$63.77 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$72.06 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$71.36 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$66.96 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$113.03 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$83.41 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$73.80 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$65.69 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$40.39 | — | — | — |